Sign In

Insurance Authority’s review of Actuarial Pricing Reports for Year 2025

15 February 2026

The year 2025 was the sixth consecutive year of insurance companies submitting actuarial reports under the Actuarial Work Rules (AWR) issued in March 2020. The primary objective of these Rules is to enhance the role and responsibilities of actuaries in the insurance sector in order to facilitate informed decision-making by management and to provide greater technical support to the business as the market sophistication continues to grow in the Kingdom.

 

Under the above Rules, an Appointed Actuary is obligated to carry out technical pricing of risks, at least annually and more frequently if business environment so demands, and report to the Senior Management, Board of Directors and the Insurance Authority (IA) the outcome of those exercises. The pricing exercises are required to be carried out for Health, Motor and Protection & Savings insurance at a minimum; the IA (or the Company management) may also require the Appointed Actuary to carry out a similar exercise for other lines of business.

 

Depending upon the appropriateness of the assumptions used, range of rating factors considered, allowance made for any regulatory changes, and credibility assigned to a client’s own claim experience, the competitive position of an insurance company is likely to be significantly dependent on the Appointed Actuary’s recommended technical prices.

 

The regulations also give discretion to a Company management to deviate from the technical prices recommended by its Appointed Actuary, provided there are adequate controls in place in the form of i) an underwriting authority matrix that specifies the deviation limit by role, ii) a requirement for the underwriter to document justification for deviation from the technical rate, and iii) quarterly reporting by the Appointed Actuary to the Board of Directors on the expected financial impact of deviating from the technical prices.

 

This document encompasses the IA’s observations from its review of the following actuarial pricing reports:

·       Health Actuarial Pricing Report (pages 3-22)

 

·       Motor Actuarial Pricing Report (pages 23-41)


·       Protection and Savings Actuarial Pricing Report (pages 42-56) 

 

A number of important observations emerged from our review. We are sharing these observations with the Company’s management together with our expectations in respect of those observations, in anticipation that management will consider each of those observations and IA expectations diligently, internal discussions will be held at the Board of Directors’ level and with all relevant functions, and appropriate actions will be taken by management.

 

Furthermore, similar to last year, a separate brief document accompanies this letter that summarizes the IA’s expectations regarding the actuarial pricing exercises going forward.

Last Modified Date: 17/03/2026 - 11:59 AM Saudi Arabia Time